Peer-reviewedCC BYEgyptian Journal of Neurosurgery
Adjuvant therapy and survival in children under three years with brain tumours: accounting for guarantee-time
- 1Department of Pediatrics, Faculty of Medicine, Inonu University
- 2Pediatric Allergy and Immunology Department, Faculty of Medicine, Inonu University
Related
- Association between adjuvant EGFR-TKI therapy and survival outcomes in completely resected stage I invasive lung adenocarcinoma (≤3 cm) with sensitizing EGFR mutations and pathological high-risk features.
- Host Determinants of Adjuvant Chemotherapy Initiation and Survival in Upper Gastrointestinal Adenocarcinoma
- Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
- Adjuvant EGFR-TKI therapy in completely resected non–small cell lung cancer with major uncommon EGFR mutations: a real-world study
- The crucial question: does adjuvant radiotherapy confer a survival benefit in pN1 oral squamous cell carcinoma (OSCC)? - A retrospective analysis.
BibTeX
@article{ozer2026adjuvant,
title = {{Adjuvant therapy and survival in children under three years with brain tumours: accounting for guarantee-time}},
author = {Nezihe Köker Özer and Ercan Yılmaz and Didem Tatar},
journal = {Egyptian Journal of Neurosurgery},
year = {2026},
month = oct,
doi = {10.1186/s41984-026-00686-9},
url = {https://doi.org/10.1186/s41984-026-00686-9},
note = {CC BY},
}
RIS
TY - JOUR
TI - Adjuvant therapy and survival in children under three years with brain tumours: accounting for guarantee-time
AU - Nezihe Köker Özer
AU - Ercan Yılmaz
AU - Didem Tatar
PY - 2026
DA - 2026/10/25
JO - Egyptian Journal of Neurosurgery
DO - 10.1186/s41984-026-00686-9
UR - https://doi.org/10.1186/s41984-026-00686-9
SN - 2520-8225
ER -